Anti-Aging Compound Linked to Cancer Risk
New research is sounding a cautionary note in the longevity space, linking an unnamed anti-aging compound to an increased risk of cancer. The findings highlight the potential dangers of unproven interventions and the need for evidence-based guidance in the biohacking community.
The molecules in question are polyamines, with spermidine being a popular supplement in the longevity space. Polyamines are naturally present in all living cells and play a crucial role in cell growth and specialization. Foods rich in spermidine include aged cheese, mushrooms, soy products, and wheat germ. This new research comes from a team at the Tokyo University of Science, led by Associate Professor Kyohei Higashi. Their study was published in the *Journal of Biological Chemistry* and utilized high-resolution proteomic techniques to analyze the impact of polyamines on over 6,700 proteins within human cancer cell lines. The study highlights a "molecular switch" mechanism. In healthy cells, polyamines interact with a protein called eIF5A1 to stimulate autophagy, a cellular cleanup process considered beneficial for aging. This is the primary basis for their reputation as "geroprotectors," or agents that protect against age-related decline. However, in cancerous or precancerous tissues, the same polyamines were found to boost the production of a closely related but different protein, eIF5A2. This second protein, eIF5A2, has been linked to aggressive tumor growth and is overexpressed in many types of cancers, including ovarian, bladder, and gastric cancers. Instead of promoting cellular cleaning, the polyamine-eIF5A2 interaction shifts the cancer cells' metabolism to favor rapid energy production through glycolysis. This metabolic shift fuels the rapid proliferation and growth characteristic of aggressive cancers. The researchers found that polyamines achieve this by disrupting a small RNA molecule that normally keeps eIF5A2 levels in check. This dual-action behavior helps explain a long-standing paradox in medical research: why a compound associated with longevity is also consistently found at high levels in tumors. The findings suggest that the biological context—healthy tissue versus potentially malignant tissue—is critical in determining the ultimate effect of polyamines. The researchers suggest that targeting the interaction between eIF5A2 and ribosomes could be a new therapeutic strategy for cancer. This could theoretically slow cancer growth without interfering with the beneficial, pro-longevity effects of the eIF5A1 protein in healthy cells. While some studies have correlated higher dietary intake of spermidine with reduced cancer-related mortality, this new research underscores the complexity of its role. It highlights a potential risk for individuals who may have undiagnosed malignancies, where supplementing with polyamines could inadvertently fuel tumor growth.
